cimadronate has been researched along with Osteolysis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashihara, E; Fuchida, S; Hatsuse, M; Ochiai, N; Okamoto, M; Okano, A; Shimazaki, C; Uchida, R; Yamada, N | 1 |
| Huang, D; Iwamoto, Y; Liu, S; Shuto, T; Xu, Q; Zhao, H | 1 |
| Alcalde, RE; Lim, DJ; Matsumura, T; Mese, H; Nakayama, S; Nishiyama, A; Sasaki, A; Yokoyama, S | 1 |
1 trial(s) available for cimadronate and Osteolysis
| Article | Year |
|---|---|
Combination therapy with thalidomide, incadronate, and dexamethasone for relapsed or refractory multiple myeloma.
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Dexamethasone; Diphosphonates; Disease-Free Survival; Female; Humans; Male; Middle Aged; Multiple Myeloma; Osteolysis; Recurrence; Thalidomide | 2005 |
2 other study(ies) available for cimadronate and Osteolysis
| Article | Year |
|---|---|
The protective effects of incadronate on inflammation and joint destruction in established rat adjuvant arthritis.
Topics: Animals; Arthritis, Experimental; Bone Density Conservation Agents; Diphosphonates; Dose-Response Relationship, Drug; Extremities; Female; Inflammation; Osteolysis; Radiography; Random Allocation; Rats; Rats, Inbred Lew; Time Factors | 2006 |
Effects of bisphosphonate on experimental jaw metastasis model in nude mice.
Topics: Animals; Breast Neoplasms; Diphosphonates; Jaw Neoplasms; Mice; Mice, Nude; Osteolysis; Tumor Cells, Cultured; Weight Gain | 1999 |